Filter Results
:
(6,093)
Show Results For
-
All HBS Web
(6,093)
- People (18)
- News (990)
- Research (3,933)
- Events (16)
- Multimedia (32)
- Faculty Publications (3,047)
Show Results For
-
All HBS Web
(6,093)
- People (18)
- News (990)
- Research (3,933)
- Events (16)
- Multimedia (32)
- Faculty Publications (3,047)
Page 1 of
6,093
Results
→
- February 2024
- Case
Finberg: Corporate Venture Capital in Turkey
By: Paul A. Gompers and Namrata Arora
In December 2021, Murat Özyeğin, Chairman of Fiba Holding, along with Ömer Mert and İhsan Elgin, engaged in discussions about the future of United Payment, a fintech company in which Finberg, a subsidiary of Fibabanka, held a 20% stake. Finberg, established in 2018 as...
View Details
- February 2006 (Revised July 2007)
- Case
Corporate Venture Capital at Eli Lilly
By: Richard G. Hamermesh, Ron Laufer and David Lane
Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity.
View Details
Hamermesh, Richard G., Ron Laufer, and David Lane. "Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, February 2006. (Revised July 2007.)
- December 2018 (Revised March 2019)
- Case
R/GA: Corporate Venture Studio vs. Accelerator
By: Andy Wu, Grant Son and Aastha Thakkar
New approach to accelerating the development of innovation through corporate venturing by creating partnerships between startup venture and established corporations through the launch of the Global Sports Venture Studios created by R/GA Ventures and the Los Angeles...
View Details
Keywords:
Start-ups;
Entrepreneurial Finance;
Corporate Venture Capital;
Incubators;
Accelerators;
Startup Financing;
Innovation;
Partnerships;
Ecosystems;
Entrepreneurship;
Business Startups;
Finance;
Venture Capital;
Partners and Partnerships;
Innovation and Invention;
Sports Industry;
Technology Industry;
Entertainment and Recreation Industry;
United States;
New York (city, NY);
Los Angeles
Wu, Andy, Grant Son, and Aastha Thakkar. "R/GA: Corporate Venture Studio vs. Accelerator." Harvard Business School Case 719-414, December 2018. (Revised March 2019.)
- January 2016 (Revised October 2016)
- Case
Saudi Aramco and Corporate Venture Capital
By: Joseph B. Fuller, Matthew Rhodes-Kropf and Nathaniel Burbank
Saudi Aramco launched an internal venture capital arm in 2011, which promptly became the world's largest investor in energy related startups. In choosing to proceed, the company's New Business Development unit (NPD) wrestled with a number of challenges. How should the...
View Details
Fuller, Joseph B., Matthew Rhodes-Kropf, and Nathaniel Burbank. "Saudi Aramco and Corporate Venture Capital." Harvard Business School Case 816-068, January 2016. (Revised October 2016.)
- 2023
- Working Paper
Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers
By: Ufuk Akcigit, Sina T. Ates, Josh Lerner, Richard Townsend and Yulia Zhestkova
The treatment of foreign investors is a contentious topic in U.S. entrepreneurship policy. We
model a setting where foreign corporate investments in Silicon Valley may allow U.S. entrepreneurs
to pursue technologies that they could not otherwise, but may also lead to...
View Details
Keywords:
Innovation;
Corporate Venture Capital;
Knowledge Spillovers;
Innovation and Invention;
Foreign Direct Investment;
Venture Capital;
Entrepreneurship;
Policy;
United States
Akcigit, Ufuk, Sina T. Ates, Josh Lerner, Richard Townsend, and Yulia Zhestkova. "Fencing Off Silicon Valley: Cross-Border Venture Capital and Technology Spillovers." Harvard Business School Working Paper, No. 21-043, September 2020. (Revised September 2023. Conditionally Accepted, Journal of Monetary Economics.)
- January 2014
- Teaching Plan
MedImmune Ventures
By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets.
View Details
Keywords:
MedImmune Ventures;
NeuProtect;
Corporate Venture Capital;
Ron Laufer;
Australia;
Starfish Ventures;
AstraZeneca;
MEVE;
Healthcare;
Startup;
Venture Capital;
Business Startups;
Health Industry;
Australia;
United States
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
- 06 Nov 2000
- Research & Ideas
The Determinants of Corporate Venture Capital Success
Corporate-sponsored venture funds first appeared in the 1960s, about two decades after the first flowering of the venture capital industry. Ever since, they have mirrored the...
View Details
Keywords:
by Paul Gompers & Josh Lerner
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer...
View Details
Keywords:
MedImmune;
MedImmune Ventures;
AstraZeneca;
NeuProtect;
Corporate Venturing;
Biotechnology;
Venture Investing;
Venture Capital;
Health Care and Treatment;
Pharmaceutical Industry;
Financial Services Industry;
Biotechnology Industry;
United States;
Australia;
Europe;
London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- October 2016
- Teaching Note
Saudi Aramco and Corporate Venture Capital
By: Joseph B. Fuller and Sarah McAra
- 22 May 2014
- News
To Crack the Glass Ceiling, Start with Venture Capital
- October 2013
- Article
Corporate Venturing
By: Josh Lerner
For decades, large companies have been wary of corporate venturing. But as R&D organizations face pressure to rein in costs and produce results, companies are investing in promising start-ups to gain knowledge and agility. The logic of corporate venturing is...
View Details
Keywords:
Venture Capital;
Knowledge Acquisition;
Corporate Strategy;
Research and Development;
Business Startups;
Innovation and Invention
Lerner, Josh. "Corporate Venturing." Harvard Business Review 91, no. 10 (October 2013): 86–94.
- November 2006 (Revised May 2007)
- Supplement
Corporate Venture Capital at Eli Lilly
Hamermesh, Richard G. "Corporate Venture Capital at Eli Lilly." Harvard Business School Video Supplement 807-705, November 2006. (Revised May 2007.)
- 29 Apr 2008
- Research Event
Venture Capital
Date: January 9-10, 2008 Faculty Chairs: Josh Lerner, William Sahlman Faculty Summary Report: Colloquium: Venture Capital What were the overall goals of the colloquium? The VC Conference is one in a series...
View Details
Venture Capital Journey
Venture Capital Journey (VCJ) is an MBA elective field course for students who plan to embark on a career in venture capital. The focus of the course is to provide students with frameworks, tools, a network, and hands on experience in preparation... View Details
- March 2017 (Revised January 2019)
- Case
Aspect Ventures
By: Paul Gompers, Danielle Li and Silpa Kovvali
Gompers, Paul, Danielle Li, and Silpa Kovvali. "Aspect Ventures." Harvard Business School Case 217-046, March 2017. (Revised January 2019.)
- Fast Answer
Corporate venture capital subsidiaries: how to identify
How can I find what firms have corporate venture capital subsidiaries? Capital IQ allows you to create a list of View Details
- September 2006
- Teaching Note
Corporate Venture Capital at Eli Lilly (TN)
By: Richard G. Hamermesh and Erin Seefeld
- October 2019 (Revised January 2020)
- Case
NewView Capital and Venture Capital Secondaries
By: Shai Bernstein, Ramana Nanda and Allison Ciechanover
While still a general partner at Silicon Valley–based New Enterprise Associates (NEA), Ravi Viswanathan considered the challenges presented by evolving market dynamics in the venture capital space. Startups were staying private longer, which led to limited partners...
View Details
Bernstein, Shai, Ramana Nanda, and Allison Ciechanover. "NewView Capital and Venture Capital Secondaries." Harvard Business School Case 820-038, October 2019. (Revised January 2020.)
- February 2013
- Article
Institutions and Venture Capital
By: Josh Lerner and Joacim Tag
We survey the literature on venture capital and institutions and present a case study comparing the development of the venture capital market in the United States and Sweden. Our literature survey underscores that the legal environment, financial market development,...
View Details
Keywords:
Venture Capital;
Organizations;
Taxation;
Entrepreneurship;
Financial Markets;
United States;
Sweden
Lerner, Josh, and Joacim Tag. "Institutions and Venture Capital." Industrial and Corporate Change 22, no. 1 (February 2013): 153–182.
The Venture Capital Cycle
In The Venture Capital Cycle, Paul Gompers and Josh Lerner correct widespread misperceptions about the nature and role of the venture capitalist and provide an accessible and comprehensive overview of the venture capital industry. Bringing together fifteen... View Details